SCHEMBL30597546

SCHEMBL30597546

Cc1cc(C)c2nc(NC(=O)N3CCNCC3)sc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.55
▸ NPC1 O15118 4/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ NFKB2 Q00653 1/20 0.55
▸ RELA Q04206 1/20 0.55
▸ MAPT P10636 8/20 0.52
▸ KDM4E B2RXH2 5/20 0.52
▸ RORC P51449 1/20 0.52
▸ RAB9A P51151 2/20 0.50
▸ HPGD P15428 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ RIPK1 Q13546 1/20 0.46
▸ LMNA P02545 4/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ LCK P06239 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597536 0.81 NPC1 (0.64) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL27004441 0.75 ALDH1A1 (0.62) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL30597545 0.74 LMNA (0.59) ALDH1A1SMN1; SMN2MAPTKDM4EHPGD
SCHEMBL16178553 0.74 DYRK1A (0.63) ALDH1A1NPC1SMN1; SMN2MAPTKDM4E
SCHEMBL27004523 0.72 ALDH1A1 (0.55) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL6711187 0.72 HTR2A (0.51) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL30597527 0.71 NPC1 (0.54) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL23657486 0.71 ALDH1A1 (0.69) ALDH1A1NPC1SMN1; SMN2NFKB1NFKB2
SCHEMBL30576750 0.70 POLB (0.59) ALDH1A1NPC1MAPTRAB9AGAA
SCHEMBL12539734 0.70 CCNT1 (0.53) ALDH1A1NPC1SMN1; SMN2KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY 2025-08-07 — — US disclosed
WO-2023201014-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF N-ACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D VANDERBILT UNIVERSITY (US) 2023-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250265-A1 BENZOTHIAZOLE-PHENYLSULFONYL-PIPERIDINE ANALOGS AS ACTIVATORS OF NACYLPHOSPHATIDYLETHANOLAMINE HYDROLYZING PHOSPHOLIPASE D PLD1, PLD2, NAPEPLD ALDH1A1 2820/4885NPC1 1992/4885SMN1; SMN2 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback